[Drug therapy of liver diseases with Hepatofalk].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003545:Cysteine / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D009963:Orotic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use*; D013831:Thiamine / Q000627:therapeutic use*; D013997:Time Factors; D014805:Vitamin B 12 / Q000627:therapeutic use*
D004338:Drug Combinations; D010936:Plant Extracts; D009536:Niacinamide; D009963:Orotic Acid; C018565:Hepatofalk; D005492:Folic Acid; D003545:Cysteine; D014805:Vitamin B 12; D013831:Thiamine
Medikamentöse Therapie von Lebererkrankungen mit Hepatofalk